25(top 100%)
PR articles
1.4K(top 20%)
PR citations
18(top 100%)
PR h-index
18(top 100%)
h-index
25
documents
1.6K
doc citations
1.2K
citing journals
100
times ranked

Publications

25 PR articles • 1,453 PR citations • Sorted by year • Download PDF (PDF by citations)
#ArticleIFPR CitationsLinks
1Hypusination of Eif5a regulates cytoplasmic TDP-43 aggregation and accumulation in a stress-induced cellular model4.216Citations (PDF)
2Arginase 1 Insufficiency Precipitates Amyloid-β Deposition and Hastens Behavioral Impairment in a Mouse Model of Amyloidosis5.122Citations (PDF)
3Aberrant AZIN2 and polyamine metabolism precipitates tau neuropathology10.741Citations (PDF)
4Myeloid Arginase 1 Insufficiency Exacerbates Amyloid-β Associated Neurodegenerative Pathways and Glial Signatures in a Mouse Model of Alzheimer’s Disease: A Targeted Transcriptome Analysis5.112Citations (PDF)
5Accumulation of C-terminal cleaved tau is distinctly associated with cognitive deficits, synaptic plasticity impairment, and neurodegeneration in aged mice
GeroScience, 2021, 44, 173-194
4.712Citations (PDF)
6Overexpression of human wtTDP-43 causes impairment in hippocampal plasticity and behavioral deficits in CAMKII-tTa transgenic mouse model2.29Citations (PDF)
7TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model9.261Citations (PDF)
8CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy5.191Citations (PDF)
9Spermidine/spermine-N1-acetyltransferase ablation impacts tauopathy-induced polyamine stress response6.743Citations (PDF)
10Altered brain arginine metabolism in a mouse model of tauopathy
Amino Acids, 2019, 51, 513-528
2.338Citations (PDF)
11Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein
NeuroMolecular Medicine, 2017, 19, 322-344
3.623Citations (PDF)
12[P4–107]: EARLY AND LONG‐LASTING INCREASES IN BRAIN ARGINASE PRODUCT IN A MOUSE MODEL OF TAUOPATHY0.40Citations (PDF)
13Targeting innate immunity for neurodegenerative disorders of the central nervous system
Journal of Neurochemistry, 2016, 138, 653-693
3.9114Citations (PDF)
14Adeno associated viral-mediated intraosseous labeling of bone marrow derived cells for CNS tracking1.57Citations (PDF)
15Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy
Journal of Neuroscience, 2015, 35, 14842-14860
3.746Citations (PDF)
16Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis9.237Citations (PDF)
17Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition6.7121Citations (PDF)
18Diverse activation of microglia by chemokine (C-C motif) ligand 2 overexpression in brain9.289Citations (PDF)
19Aging enhances classical activation but mitigates alternative activation in the central nervous system
Neurobiology of Aging, 2013, 34, 1610-1620
3.4116Citations (PDF)
20Fractalkine overexpression suppresses tau pathology in a mouse model of tauopathy
Neurobiology of Aging, 2013, 34, 1540-1548
3.4101Citations (PDF)
21Intracranial Injection of AAV Expressing NEP but Not IDE Reduces Amyloid Pathology in APP+PS1 Transgenic Mice
PLoS ONE, 2013, 8, e59626
2.438Citations (PDF)
22Convection-enhanced delivery and systemic mannitol increase gene product distribution of AAV vectors 5, 8, and 9 and increase gene product in the adult mouse brain2.265Citations (PDF)
23Trafficking CD11b-Positive Blood Cells Deliver Therapeutic Genes to the Brain of Amyloid-Depositing Transgenic Mice
Journal of Neuroscience, 2010, 30, 9651-9658
3.7122Citations (PDF)
24LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice9.2270Citations (PDF)
25Chemical Manipulation of Hsp70 ATPase Activity Regulates Tau Stability
Journal of Neuroscience, 2009, 29, 12079-12088
3.7229Citations (PDF)